Company: INGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029993
Chunk: 76

Company: Inogen Inc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 76
---

    23

    Additional paid-in capital

    328,174

    320,513

    Accumulated deficit

    (152,837
    )

    (116,949
    )

    Accumulated other comprehensive income (loss)

    (1,501
    )

    1,225

    Total stockholders' equity

    173,860

    204,812

    Total liabilities and stockholders' equity
     
    $
    296,185

    $
    326,194

See accompanying notes to the consolidated financial statements.

 F-4

Inogen, Inc. 

Consolidated Statements of Comprehensive Loss 

(amounts in thousands, except share and per share amounts) 

    Years Ended December 31,

    2024

    2023

    2022

    Revenue

    Sales revenue
     
    $
    278,756

    $
    251,607

    $
    320,549

    Rental revenue

    56,949

    64,053

    56,692

    Total revenue

    335,705

    315,660

    377,241

    Cost of revenue

    Cost of sales revenue

    148,655

    158,636

    197,805

    Cost of rental revenue, including depreciation of $12,592, $12,893 and

    $11,103, respectively

    32,309

    30,325

    25,903

    Total cost of revenue

    180,964

    188,961

    223,708

    Gross profit

    Gross profit-sales revenue

    130,101

    92,971

    122,744

    Gross profit-rental revenue

    24,640

    33,728

    30,789

    Total gross profit

    154,741

    126,699

    153,533

    Operating expense

    Research and development

    21,610

    20,840

    21,943

    Sales and marketing

    103,069

    107,091

    120,767

    General and administrative

    72,578

    75,260

    43,905

    Loss on disposal of intangible asset